HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1

Historical Institutional Holders from Q3 2023 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Debt / NOTE 1.000% 8/1
Principal, excl. options Q4 2024
672M
Holdings value Q4 2024
$729M
Value change Q4 2024
-$63.1M
Grand Portfolio weight change Q4 2024
0%
Number of holders
76
Number of buys Q4 2024
33
Number of sells Q4 2024
-33
Average buys Q4 2024 %
+0.002%
Average sells Q4 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q4 $672M $729M -$63.1M $1.08 77
2024 Q3 $680M $810M +$105M $1.19 75
2024 Q2 $24B $717M -$3.71M $1.11 72
2024 Q1 $623M $607M -$28.9M $0.97 69
2023 Q4 $658M $615M +$10.1M $0.93 70
2023 Q3 $644M $608M +$606M $0.94 62